Drawing for IAGE

USPTO serial 88368478

IAGE

Reviewed by CopyMark Law Group

Reg. 6342202Status 700Renewal
Filing date
Status date
Registration date
May 4, 2021
Examiner
PETTICAN, NATHANIEL VINCIENT
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with IAGE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $299*

Plus Government fees of $325

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Thomas D. Foster

Thomas D. Foster TDFoster - Intellectual Property Law11622 El Camino Real, Suite 100San Diego, CA 92130UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
044Medical testing for diagnostic and treatment purposes in the fields of chronic inflammation, wellness, anti-aging, general health and well being; Providing medical information to healthcare professionals in the form of reports in the fields of cardiology, immunology, oncology, neurology, primary care, preventive and functional medicineACTIVEJan 1, 2020

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 4, 2026REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jun 5, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 5, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 5, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 4, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 30, 2021SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Mar 29, 2021CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Mar 20, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 20, 2021SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Mar 20, 2021AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Mar 10, 2021ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Mar 2, 2021IUAFUSE AMENDMENT FILED—
Mar 2, 2021EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Sep 26, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 24, 2020EX2GSOU EXTENSION 2 GRANTED—
Sep 24, 2020EXT2SOU EXTENSION 2 FILED—
Sep 24, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 26, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 24, 2020EX1GSOU EXTENSION 1 GRANTED—
Mar 24, 2020EXT1SOU EXTENSION 1 FILED—
Mar 24, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 25, 2019TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 25, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 25, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 1, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 6, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 6, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 17, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 1, 2019ALIEASSIGNED TO LIE—
Jun 21, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 20, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Jun 20, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 20, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 20, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 12, 2019DOCKASSIGNED TO EXAMINER—
Apr 20, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 5, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance